Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)

Genet Med. 2020 Jul;22(7):1142-1148. doi: 10.1038/s41436-020-0783-8. Epub 2020 Apr 23.
No abstract available

Keywords: next-generation sequencing (NGS); presumed germline pathogenic variants (PGPV); secondary findings; somatic variants; tumor testing.

MeSH terms

  • Genetic Testing
  • Genetics, Medical*
  • Genome, Human
  • Genomics
  • Germ Cells
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / genetics
  • United States